How many live with lung cancer?

.
.

There are two main types of oncological lesions of the broncho-pulmonary system - small cell and non-small cell. In general, pulmonary neoplasms are difficult to treat. In addition, they are often diagnosed at advanced stages, which affects the effectiveness of selected techniques and indicates a low percentage of favorable outcome.

The answer to the question: "How many live with lung cancer? "Foresees the establishment of an exact histological type, because the information on survival will be significantly different.

Of all people with non-small cell neoplasm, only 30% have a tumor that is limited by the organ. In other cases, this is a rather advanced pathology, which is characterized by a disappointing prognosis. Even with treatment, only about 25 people with pulmonary tumors include a two-year survival.

What determines how many live with lung cancer?

The likely outcome for a malignant disease of the pulmonary system is associated with such conditions as:

  1. A specific type of oncological lesion, named depending on the image of the cells under the microscope. They can be large or small.
  2. A period in which a cancer invasion is diagnosed and, accordingly, involvement in the oncological process of other body tissues.
  3. The choice of treatment and response. 5-year survival for people with a distant tumor, which did not spread beyond the body, is 35-40%.
  4. Age. Some studies note that individuals younger than 30 years who underwent surgical excision in the early stages have an 85% chance of surviving for 4 years.
  5. Speed ​​of propagation.
  6. The presence of other diseases.
  7. Individual perception and tolerability of therapeutic measures.
  8. Participation in innovative modern trials, which often contribute to increasing efficiency and longevity, as well as reaction to them.

Important to know: Death from lung cancer

.
.

How many live with lung cancer, depending on the stage

When determining statistics, the view is also taken into account.

Non-small cell lung cancer

Step I:

Characterized by the best indicators. The possibility of using surgical resection further improves the results:

  • at 1A, 58 to 73 people out of 100 will live for at least five years after the diagnosis. The average median duration of the life cycle is 60 months;
  • at 1V, every 44-59 people survive after the diagnosis of the disease. On average, the life expectancy of such patients is 36 months.

Stage II:

Also divided into sub-stages 2A and 2B:

2A indicates 36-46% of survivors after 5 years. The average life cycle is 24 months. But patients necessarily adhered to appropriate therapy.

In phase 2B, chances are reduced to 25-36%, and life-span information indicates 20 months.

Stage IIІ:

At the third stage, the statistics document a sharp fall in the life cycle:

  • for 3A, the five-year survival rate is the percentage of patients between 19 and 24. Average duration is 15 months (less, year);
  • at phase 3B, the number of patients who will live five years, varies from 7 to 9. The chances for a long-term forecast are often not more than a year.

IV stage:

The statistics for the IV stage are the least optimistic. But they make up a wide range of survival: from 2% to 13. These indicators are higher than for 3B. This situation means that the total number of patients with cancer diagnosed at the last stage is more. Otherwise, in these patients, the tumor progresses more slowly than in stage 3B. On average, the life of people with the 4 form lasts up to one year (about 8 months).

Small cell lung cancer

Sometimes doctors divide this subtype of lung cancer into only 2 large groups:

  1. Limited malignant compaction (the mutation did not expand beyond the body).
  2. Extensive disease: the process is observed in other structures.

I stage:

Has good predictive expectations. Although general information on survival for those affected by this type is significantly worse.

Doctors also divide this group into the following subspecies:

  • 1A: almost every 40 patients from 100 diagnosed survive to the five-year boundary, from the moment of detection of malignant formation;
  • already at 1V survivors is half as much: there are about 20% of cases of 5-year survival.

II stage:

It is divided into two. Information about life duration differs little from the original process.

2A indicates 40 people out of 100 who will live with a diagnosis for at least several years;

2B informs that the number of survivors will be halved, that is, it will become 20%.

Stage IIІ:

Also indicates a drop in survival:

3A: almost 15% of oncologists are alive after 5 years after the first diagnosis;

3B: only about 10 out of every 100 with a corresponding diagnosis can hope for a five-year survival.

IV stage:

For the terminal stage of lung cancer, statistical factors are very low. Only 1 person out of 100 will have a life expectancy exceeding two years.

This is important: How much can you live with in lung cancer?

Forecast

Unfortunately, in comparison with some other types of oncology, pulmonary cancer has not very positive statistics. General data, regardless of the stage and form, for the non-small cell form become:

  1. 30% of patients with different forms of malignant lung disease will live at least one year after diagnosis.
  2. Every 10 out of 100 people will live for 5 years from the diagnosis.
  3. About 6 people (6%) will survive after 10 years.

At the time of the diagnosis of small cell malignancy, 2 out of 3 patients with cancer have extensive damage. Even with intensive care, only 5 out of every 100 will survive the end of the five-year period of struggle.

For today, scientists around the world are testing various tests. Therefore, it is possible, soon,how many live with lung cancer, will change for the better.

.
.
.
.